Given oestradiol induces proliferation and downregulates CD36 in several breast cancer cell lines [38], a mechanism similar to this might also be operating in breast cancer (Figure 2), suggesting oestradiol could promote the malignancy of breast cancer in a CD36-dependent manner, by downregulating MEDA-4. This evidence concerns the gene MEDAG and breast carcinoma.